Compass Pathways Stock

Compass Pathways Shares Outstanding

The The number of shares of Compass Pathways (CMPS) as of Sep 6, 2026 is 113.50 M. In the previous year, The number of shares was 113.50 M — a change of 0.00% (lower).

Shares Outstanding

113.50 M

YoY

0.00%

Last updated:

In 2026, Compass Pathways had 113.50 M outstanding stocks, a 0.00% change from the 113.50 M stocks in the previous year.

The Compass Pathways Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2023
113.50 M USD
Jan 1, 2024
113.50 M USD
Jan 1, 2025
113.50 M USD
Jan 1, 2026 (e)
93.64 USD
Jan 1, 2027 (e)
93.64 USD
Jan 1, 2028 (e)
93.64 USD
Jan 1, 2029 (e)
93.64 USD
Jan 1, 2030 (e)
93.64 USD
The Compass Pathways Shares Outstanding history
YEARShares OutstandingYoY
est93.640.00%
est93.640.00%
est93.640.00%
est93.640.00%
est93.64-100.00%
113.50 M0.00%
113.50 M0.00%
113.50 M0.00%
113.50 M0.00%
113.50 M0.00%
113.50 M0.00%
113.50 M0.00%
113.50 M
Access this data via the Eulerpool API

Compass Pathways Number of shares

Compass Pathways shares outstanding

The number of shares of Compass Pathways was 93.64 M in 2025. This indicates how many shares Compass Pathways is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2023
61.96 M Stocks
Jan 1, 2024
68.47 M Stocks
Jan 1, 2025
93.64 M Stocks
Jan 1, 2026 (e)
93.64 M Stocks
Jan 1, 2027 (e)
93.64 M Stocks
Jan 1, 2028 (e)
93.64 M Stocks
Jan 1, 2029 (e)
93.64 M Stocks
Jan 1, 2030 (e)
93.64 M Stocks

Compass Pathways Stock analysis

What does Compass Pathways do? Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Compass Pathways's Shares Outstanding

Compass Pathways's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Compass Pathways’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Compass Pathways’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Compass Pathways’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Compass Pathways stock

The number of shares of Compass Pathways is 113.50 M in 2026.

The number of shares of Compass Pathways changed from 113.50 M to 113.50 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Compass Pathways since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

Other — Compass Pathways

All Key Metrics — Compass Pathways